Highlights RVL Pharmaceuticals plc

Equities

RVLPQ

IE00BF2HDL56

Market Closed - OTC Markets Other stock markets 20:23:55 10/05/2024 BST			5-day change	1st Jan Change
0.000001 ^USD	-99.80%		-99.80%	-99.97%

04-12	North American Morning Briefing : Big Banks Kick -2-	DJ
03-21	North American Morning Briefing : Investors -2-	DJ

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Investors -2-	03-21	DJ
North American Morning Briefing : TSMC Results -2-	01-18	DJ
North American Morning Briefing : S&P 500 Futures Just Shy of Record High	12-28	DJ
Earnings Flash (RVLP) RVL PHARMACEUTICALS Posts Q2 Revenue $8.3M, vs. Street Est of $10.3M	14/08/23	MT
RVL Pharmaceuticals plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Earnings Flash (RVLP) RVL PHARMACEUTICALS Reports Q1 Revenue $8.8M, vs. Street Est of $9.2M	11/05/23	MT
RVL Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23	CI
RVL Pharmaceuticals plc Reports Earnings Results for the Full Year Ended December 31, 2022	20/03/23	CI
RVL Pharmaceuticals plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	20/03/23	CI
RVL Pharmaceuticals plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	20/03/23	CI
Earnings Flash (RVLP) RVL PHARMACEUTICALS Posts Q4 Revenue $9.8M, vs. Street Est of $12.5M	20/03/23	MT
Earnings Flash (RVLP) RVL PHARMACEUTICALS Posts Q3 Revenue $10M	10/11/22	MT
RVL Pharmaceuticals plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22	CI
RVL Pharmaceuticals plc Reaffirms Sales Guidance for the Fourth Quarter of 2022	10/11/22	CI
RVL Pharmaceuticals Expects 19% Sequential Increase in Upneeq Product Q3 Sales	18/10/22	MT
RVL Pharmaceuticals Expects 19% Sequential Increase in Upneeq Product Q3 Sales	18/10/22	MT
RVL Pharmaceuticals plc Revises Sales Guidance for the Fourth Quarter of 2022	18/10/22	CI
RVL Pharmaceuticals to Form Marketing Partnership With Revision Skincare	30/08/22	MT
Revision Skincare® Announces Strategic Partnership with RVL Pharmaceuticals plc	30/08/22	CI
Earnings Flash (RVLP) RVL PHARMACEUTICALS Reports Q2 Revenue $8.4M, vs. Street Est of $8.52M	11/08/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights RVL Pharmaceuticals plc

Equities

RVLPQ

IE00BF2HDL56

Highlights

Filters